Jaime Vieser - 24 Jun 2025 Form 4 Insider Report for Alaunos Therapeutics, Inc. (TCRT)

Reporting relationship
Director
Issuer ticker
TCRT
Reported as of
24 Jun 2025
Net transaction value
+$1,122
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
26 Jun 2025, 21:22:46 UTC
Prior SEC filing
15 Apr 2025
Next SEC filing
07 Jul 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Melinda Lackey

Key filing fact

Jaime Vieser filed Form 4 for Alaunos Therapeutics, Inc. (TCRT) on 26 Jun 2025.

Key facts

  • This page summarizes Jaime Vieser's Form 4 filing for Alaunos Therapeutics, Inc. (TCRT).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 26 Jun 2025, 21:22.

Change

  • Previous filing in this sequence was filed on 15 Apr 2025.
  • Current net transaction value: +$1,122.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001846045 Primary reporting owner

Vieser Jaime

Relationship
Director
Address
C/O ALAUNOS THERAPEUTICS, INC., 2617 BISSONNET ST, SUITE 233, HOUSTON
Signature
/s/ Melinda Lackey
Signature date
26 Jun 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TCRT transaction Derivative

Series A-2 Convertible Preferred Stock

Purchase

Transaction value
$1,122
Shares
+250
Change %
Price
$4.49
Shares after
250
Date
24 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
55,679
Exercise price
$4.49
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The preferred stock is perpetual and therefore has no expiration date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .